A significant reduction in RNA levels, 36.1-times for IRX2 (Padj=0.0001) and 2.6-times for IRX5 (Padj=0.03), was observed in PPB patients compared to controls, as in Yy1 mouse mutants. This evidence concerns the gene IRX5 and pleuropulmonary blastoma.